SPIRE SIGN IN Register

Spirethoughts

Spire's six most recent Spirethoughts.

Will cost-effective compost rejuvenate African agriculture
Will compost turn out to be the magic mineral for African agriculture?
Will emerging countries dominate the pool of global megacities in futu...
Thumbnail_Will the tech sector create new employment opportunities for persons with disabilities
Will the tech sector create new employment opportunities for persons w...
Thumbnail_Spirethoughts_Can permanent research bases for human beings be built on the moon
Will 3D printing enable the construction of permanent facilities on th...
Will Africa become the latest global aviation hot-spot
Will Africa become the latest global aviation hot-spot?
Will air taxis become the latest urban transport innovation_
Will air taxis become the latest urban transport innovation?

India’s generic drug industry heading for change

The India Supreme Court recently rejected drug maker Novartis AG’s attempt to patent an updated version of a cancer drug. This would ensure patients across the globe would have access to cheaper versions of lifesaving medicines, such as Glivec, that is used to treat chronic myeloid leukemia. With a generic and more affordable medicine available at a huge price difference, this could be the difference between life and death.

On the other hand, this decision also means that India’s USD26 billion generic drug industry, which supplies most cheap medicines across the developing world could slow down. Many other international pharmaceutical companies are now re-thinking their strategies for the Indian market. Nonetheless, it signifies that Indian companies will now have added legal coverage to produce and export low-cost generic drugs.

How would giving the world access to cheaper medicines affect India?

Back to Top

Back to Home
BTBTBTBTBTBT